SRSF2 and chronic myelomonocytic leukemia: Around 20–30% of patients with CMML have cytogenetic abnormalities at diagnosis [6] and almost 90% harbor at least one somatic mutation, most frequently of TET2, SRSF2, and ASXL1 [7].